Hongyan Zhou Selected Research

HLA-DR53

5/2009	Polymorphisms of FCRL3 in a Chinese population with Vogt-Koyanagi-Harada (VKH) syndrome.
1/2008	Small ubiquitin-like modifier 4 (SUMO4) polymorphisms and Vogt-Koyanagi-Harada (VKH) syndrome in the Chinese Han population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hongyan Zhou Research Topics

Disease

22	Inflammation (Inflammations) 01/2024 - 04/2002
16	Neoplasms (Cancer) 09/2023 - 06/2011
15	Uveitis 08/2021 - 03/2002
9	Autoimmune Diseases (Autoimmune Disease) 08/2021 - 05/2007
8	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 08/2009 - 04/2002
7	Hypersensitivity (Allergy) 12/2014 - 06/2006
6	Corneal Neovascularization 09/2023 - 05/2011
6	Behcet Syndrome (Behcet's Syndrome) 10/2010 - 04/2002
3	Cognitive Dysfunction 12/2023 - 01/2022
3	Body Weight (Weight, Body) 01/2023 - 07/2008
3	Hemorrhage 11/2021 - 03/2012
3	Breast Neoplasms (Breast Cancer) 07/2020 - 01/2015
2	Liver Neoplasms (Liver Cancer) 03/2024 - 07/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2024 - 01/2018
2	Stroke (Strokes) 10/2023 - 01/2015
2	Hepatocellular Carcinoma (Hepatoma) 09/2023 - 02/2022
2	Heart Failure 01/2023 - 01/2004
2	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2022
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 11/2017
2	Fibrosis (Cirrhosis) 01/2022 - 10/2016
2	Hypertension (High Blood Pressure) 01/2022 - 07/2018
2	Communicable Diseases (Infectious Diseases) 07/2021 - 12/2010
2	Infections 11/2019 - 01/2011
2	Stomach Neoplasms (Stomach Cancer) 12/2017 - 01/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2016 - 01/2012
2	Keratitis 01/2016 - 10/2010
2	Prostatic Neoplasms (Prostate Cancer) 06/2014 - 03/2012
2	Pathologic Constriction (Stenosis) 09/2013 - 09/2013
2	Wounds and Injuries (Trauma) 05/2011 - 01/2011
1	Hypothyroidism 01/2024
1	Metabolic Diseases (Metabolic Disease) 01/2024
1	Rheumatic Diseases (Rheumatism) 01/2024
1	Thymoma (Thymic Carcinoma) 01/2024
1	Hyperuricemia 01/2024
1	Macular Degeneration (Age-Related Maculopathy) 01/2024
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2024

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2024 - 03/2007
9	AntigensIBA 08/2021 - 03/2002
8	Retinaldehyde (Retinal)IBA 08/2021 - 04/2002
6	Messenger RNA (mRNA)IBA 01/2021 - 03/2007
6	AlkaliesIBA 01/2019 - 05/2011
5	CytokinesIBA 07/2021 - 01/2011
5	Interleukin-17 (Interleukin 17)IBA 12/2014 - 05/2007
4	OvalbuminIBA 02/2016 - 06/2006
3	LipidsIBA 01/2024 - 07/2008
3	VaccinesIBA 12/2023 - 07/2008
3	Oxygen (Dioxygen)IBA 05/2019 - 12/2015
3	Small Interfering RNA (siRNA)IBA 05/2018 - 01/2015
3	LigandsIBA 06/2014 - 05/2011
3	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2011 - 04/2002
3	Interleukin-23 (Interleukin 23)IBA 07/2010 - 05/2007
2	Hormones (Hormone)IBA 01/2024 - 03/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 01/2018
2	amsonic acid (DAS)IBA 09/2023 - 02/2022
2	CateninsIBA 09/2023 - 01/2022
2	allyl sulfideIBA 09/2023 - 02/2022
2	Amyloid (Amyloid Fibrils)IBA 01/2023 - 10/2008
2	Therapeutic UsesIBA 01/2023 - 09/2013
2	AlbuminsIBA 05/2022 - 11/2017
2	Estrogens (Estrogen)FDA Link 02/2022 - 02/2014
2	Neuroprotective AgentsIBA 01/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2015
2	Long Noncoding RNAIBA 01/2022 - 07/2020
2	GlucocorticoidsIBA 01/2022 - 05/2019
2	AutoantigensIBA 08/2021 - 04/2009
2	interstitial retinol-binding proteinIBA 08/2021 - 01/2018
2	SolutionsIBA 01/2021 - 02/2016
2	AntibodiesIBA 10/2020 - 10/2014
2	Toll-Like Receptor 3IBA 01/2019 - 06/2011
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 08/2018
2	RotenoneIBA 01/2018 - 01/2012
2	Interleukin-1 (Interleukin 1)IBA 01/2017 - 12/2015
2	InterleukinsIBA 01/2017 - 12/2015
2	EnzymesIBA 11/2016 - 10/2008
2	Matrix Metalloproteinases (MMPs)IBA 02/2016 - 10/2010
2	AndrogensIBA 06/2014 - 03/2012
2	Androgen Receptors (Androgen Receptor)IBA 06/2014 - 03/2012
2	Poly I-CIBA 06/2011 - 10/2010
2	HMGB1 Protein (HMG1)IBA 06/2011 - 05/2011
2	Monocyte Chemoattractant ProteinsIBA 01/2010 - 08/2009
2	HLA-DR53IBA 05/2009 - 01/2008
2	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 05/2009 - 01/2008
2	Interleukin-23 Subunit p19IBA 07/2008 - 05/2007
1	Methimazole (Thiamazole)FDA LinkGeneric 01/2024
1	Antithyroid Agents (Antithyroid Drugs)IBA 01/2024
1	Complement Factor B (Factor B)IBA 01/2024
1	Uric Acid (Urate)IBA 01/2024
1	Mitogen-Activated Protein KinasesIBA 01/2024
1	purineIBA 01/2024
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2024
1	Complement System Proteins (Complement)IBA 01/2024

Therapy/Procedure

12	Therapeutics 01/2024 - 01/2011
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2024 - 04/2002
2	Immunotherapy 08/2021 - 01/2019
2	Punctures 06/2017 - 05/2016
2	Aftercare (After-Treatment) 09/2013 - 04/2002
1	Precision Medicine 03/2024
1	Contact Lenses 01/2024
1	Thymectomy 01/2024
1	Continuous Positive Airway Pressure 12/2023